BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
First published online December 10, 2007
British Journal of Radiology (2008) 81, 120-128
© 2008 British Institute of Radiology
doi: 10.1259/bjr/98435332
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by RADJENOVIC, A
Right arrow Articles by SMITH, M A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by RADJENOVIC, A
Right arrow Articles by SMITH, M A

Full paper

Measurement of pharmacokinetic parameters in histologically graded invasive breast tumours using dynamic contrast-enhanced MRI

A RADJENOVIC, MSc, PhD 1 B J DALL, FRCR 2 J P RIDGWAY, MSc, PhD 3 and M A SMITH, PhD, DSc, FInstP 4

1 Academic Unit of Medical Physics, University of Leeds, Leeds, Departments of 2 Radiology and 3 Medical Physics, Leeds Teaching Hospitals NHS Trust, Leeds and 4 Sheffield Hallam University, Sheffield, UK

Correspondence: Dr Aleksandra Radjenovic, Research Fellow, Academic Unit of Medical Physics, University of Leeds, Level 10, Worsley Building, Clarendon Way, Leeds LS2 9JT, UK. E-mail: sasha{at}medphysics.leeds.ac.uk

Dynamic contrast-enhanced MRI (DCE-MRI) has demonstrated high sensitivity for detection of breast cancer. Analysis of correlation between quantitative DCE-MRI findings and prognostic factors (such as histological tumour grade) is important for defining the role of this technique in the diagnosis of breast cancer as well as the monitoring of neoadjuvant therapies. This paper presents a practical clinical application of a quantitative pharmacokinetic model to study histologically confirmed and graded invasive human breast tumours. The hypothesis is that, given a documented difference in capillary permeability between benign and malignant breast tumours, a relationship between permeability-related DCE-MRI parameters and tumour aggressiveness persists within invasive breast carcinomas. In addition, it was hypothesized that pharmacokinetic parameters may demonstrate stronger correlation with prognostic factors than the more conventional black-box techniques, so a comparison was undertaken. Significant correlations were found between pharmacokinetic and black-box parameters in 59 invasive breast carcinomas. However, statistically significant variation with tumour grade was demonstrated in only two permeability-related pharmacokinetic parameters: kep (p<0.05) and Ktrans (p<0.05), using one-way analysis of variance. Parameters kep and Ktrans were significantly higher in Grade 3 tumours than in low-grade tumours. None of the measured DCE-MRI parameters varied significantly between Grade 1 and Grade 2 tumours. Measurement of kep and Ktrans might therefore be used to monitor the effectiveness of neoadjuvant treatment of high-grade invasive breast carcinomas, but is unlikely to demonstrate remission in low-grade tumours.




This article has been cited by other articles:


Home page
 RadiologyHome page
M. Oostendorp, M. J. Post, and W. H. Backes
Vessel Growth and Function: Depiction with Contrast-enhanced MR Imaging
Radiology, May 1, 2009; 251(2): 317 - 335.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2008 by the British Institute of Radiology.